TLPH
Talphera Inc.NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$43.08M
P/E Ratio
—
EPS
$-0.28
Beta
0.79
52W High
$1.57
52W Low
$0.38
50-Day MA
$0.82
200-Day MA
$0.97
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.02
PEG Ratio
—
About Talphera Inc.
Talphera Inc. is a forward-thinking biotechnology company dedicated to creating pioneering peptide-based therapies for rare diseases and addressing significant unmet medical needs. With a promising pipeline concentrated on innovative cancer treatments and other high-need health sectors, Talphera is positioned for substantial growth. The company's commitment to research excellence combined with its focus on transformative healthcare solutions presents a compelling investment opportunity for institutional investors looking to capitalize on advancements in the biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 1,000 |
| Gross Profit (TTM) | -245,000 |
| EBITDA | $-15.16M |
| Operating Margin | -1451600.00% |
| Return on Equity | -118.40% |
| Return on Assets | -40.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.34 |
| Price-to-Book | 2.27 |
| Price-to-Sales (TTM) | 43076.71 |
| EV/Revenue | 20842.49 |
| EV/EBITDA | 0.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $51.90M |
| Float | $26.75M |
| % Insiders | 21.38% |
| % Institutions | 34.76% |
Historical Volatility
HV 10-Day
68.31%
HV 20-Day
59.90%
HV 30-Day
55.05%
HV 60-Day
68.57%
HV Rank
8.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($3.17 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026